The novel guanidine ME10092 protects the heart during ischemia–reperfusion

This publication has 22 references indexed in Scilit:

• N-Hydroxyguanidine Compound 1-(3,4-Dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine Inhibits the Xanthine Oxidase Mediated Generation of Superoxide Radical
  Archives of Biochemistry and Biophysics, 2000
• In vivo models of myocardial ischemia and reperfusion injury: Application to drug discovery and evaluation
  Journal of Pharmacological and Toxicological Methods, 2000
• Metabolic aspects of programmed cell survival and cell death in the heart
  Published by Oxford University Press (OUP) ,2000
• Reperfusion injury: Experimental evidence and clinical implications
  American Heart Journal, 1999
• Effect of sodium-hydrogen exchange inhibition on functional and metabolic impairment produced by oxidative stress in the isolated rat heart
  Canadian Journal of Physiology and Pharmacology, 1997
• Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options
  International Journal of Cardiology, 1997
• Antioxidant Activity of U-83836E, A Second Generation Lazaroid, During Myocardial Ischemia/Reperfusion Injury
  Free Radical Research, 1997
• Improvement of Cardiac Function by Allopurinol in Patients Undergoing Cardiac Surgery
  Journal of Cardiovascular Pharmacology, 1995
• Guanabenz: A centrally acting, natriuretic antihypertensive drug
  Kidney International, 1986
• An investigation into the characteristics of reperfusion‐induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents
  British Journal of Pharmacology, 1984